Growth Hormone Deficiency

Condition: Growth Hormone Deficiency  |  Category: Longevity and Hormonal Health  |  Reviewed by: Brian Lamkin, DO

What Is Adult Growth Hormone Deficiency?

Growth hormone (GH) is secreted by the anterior pituitary in pulsatile bursts, primarily during deep sleep and high-intensity exercise. It stimulates the liver to produce insulin-like growth factor 1 (IGF-1), which mediates the majority of GH's anabolic and regenerative effects: muscle protein synthesis, bone mineralization, lipolysis (fat breakdown), collagen production, immune function, and neuronal repair.

GH secretion declines approximately 14 percent per decade after age 30, a process called somatopause. By age 60, most adults produce less than half the GH they produced at age 25. This decline is accepted as "normal aging," but the rate and magnitude of decline are heavily influenced by modifiable factors: sleep quality, body composition (particularly visceral fat), insulin sensitivity, cortisol levels, and exercise intensity. The distinction between aging and accelerated decline from lifestyle and metabolic factors is central to the functional medicine approach.

Why Growth Hormone Matters

Common Symptoms

Root Causes: A Functional Medicine Perspective

GH secretion is controlled by the balance between growth hormone releasing hormone (GHRH, stimulatory) and somatostatin (inhibitory). The modifiable factors that suppress GH all operate through this axis.

Sleep Disruption

The largest GH secretion pulse occurs during the first cycle of slow-wave (deep) sleep, typically 60 to 90 minutes after sleep onset. This pulse accounts for up to 70 percent of daily GH production. Sleep apnea, insomnia, delayed sleep onset, and reduced deep sleep percentage all suppress this pulse. Improving sleep architecture is the single most impactful intervention for GH optimization.

Visceral Adiposity

Visceral fat directly suppresses GH secretion through elevated somatostatin, increased free fatty acids that inhibit GH release, and the hyperinsulinemia that accompanies visceral adiposity. This creates a self-reinforcing cycle: low GH promotes fat storage, and fat storage suppresses GH further. Breaking this cycle requires addressing both the metabolic and the hormonal components simultaneously.

Insulin Resistance and Hyperinsulinemia

Insulin and GH have a reciprocal relationship. Hyperinsulinemia directly suppresses GH secretion. Chronically elevated insulin produces a tonic inhibition of pituitary GH release. Improving insulin sensitivity through dietary modification, exercise, and metabolic intervention removes this suppressive signal. Many patients experience measurable IGF-1 improvement from insulin sensitization alone.

Cortisol Excess

Chronic cortisol elevation suppresses the GH axis at the hypothalamic level and shifts metabolism from anabolic (tissue building) to catabolic (tissue breakdown). Cortisol directly antagonizes GH effects on muscle and bone. HPA axis dysregulation producing elevated evening cortisol is particularly damaging because it suppresses the nocturnal GH secretion window.

Conventional vs Functional Medicine Approach

Key Labs to Evaluate

How to Interpret These Labs Together

Common Patterns Seen in Patients

• The 52-year-old executive who "can't lose belly fat": exercises 4 times per week, eats well, gaining visceral fat progressively. IGF-1 low-normal. Fasting insulin elevated (16). Sleeps 5.5 hours with disrupted sleep architecture from work stress. The combination of insulin-driven GH suppression, sleep-driven loss of the nocturnal GH pulse, and cortisol-driven catabolic shift is producing body composition deterioration that exercise alone cannot overcome. Sleep optimization, insulin sensitization, and cortisol management produced visible body composition improvement within 8 weeks alongside rising IGF-1.
• The 45-year-old woman whose muscle tone is disappearing: progressive loss of muscle definition despite consistent resistance training. Recovery from workouts taking 3 to 4 days instead of 1 to 2. IGF-1 in the lower quarter of the reference range. Sleep quality declining. Deep sleep percentage 8 percent (optimal greater than 20 percent). Sleep architecture restoration plus exercise timing optimization (high-intensity training earlier in the day to enhance deep sleep percentage) improved IGF-1 and recovery capacity within 6 weeks.
• The patient on testosterone replacement with incomplete results: testosterone optimized to upper third of range. Visceral fat persists. Muscle response inadequate. IGF-1 low. Testosterone and GH are synergistic. Without adequate GH/IGF-1, testosterone's anabolic effects are attenuated. Addressing the GH axis (sleep, insulin sensitization, body composition) alongside testosterone optimization produced the body composition and vitality results that testosterone alone could not.

Treatment and Optimization Strategy

Restoring GH Secretory Capacity

What Most Doctors Miss

• IGF-1 is not measured: the marker that reflects GH activity is absent from standard labs. Age-related GH decline is accepted as normal without any attempt to quantify or modify it.
• The modifiable factors are treated as unrelated conditions: the patient's insulin resistance, poor sleep, visceral fat, and elevated cortisol are each treated independently without recognizing that they form a GH-suppressive cluster that can be addressed as a unified mechanism.
• Sleep is the most impactful GH lever and the most overlooked: 70 percent of daily GH production occurs during deep sleep. No supplement, peptide, or exercise protocol can replace the GH pulse lost from poor sleep architecture.
• GH optimization is conflated with GH abuse: restoring physiologic GH secretion through lifestyle and metabolic optimization is fundamentally different from supraphysiologic GH dosing. The clinical context is health-span and longevity, not performance enhancement.

When to Seek Medical Care

If you are experiencing progressive visceral fat accumulation despite exercise, difficulty building or maintaining muscle, prolonged recovery from workouts, declining exercise capacity, cognitive changes, or loss of skin quality and collagen, IGF-1 measurement alongside comprehensive metabolic evaluation is warranted. These symptoms overlap with testosterone, thyroid, and cortisol dysfunction, making a comprehensive hormonal assessment the appropriate starting point.

Recommended Testing

Frequently Asked Questions

How The Lamkin Clinic Approaches Growth Hormone Optimization

At The Lamkin Clinic, growth hormone evaluation includes IGF-1 as the primary marker, comprehensive metabolic assessment (fasting insulin, HbA1c), hormonal evaluation (testosterone, thyroid, cortisol), body composition analysis, and sleep quality assessment. Treatment begins with sleep optimization, exercise programming, insulin sensitization, and cortisol management. When lifestyle optimization alone is insufficient, GH secretagogue peptide therapy is available to restore physiologic GH pulsatility.

Related Conditions

Related Symptoms